Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  • M. K. Han
  • G. J. Criner
  • M. T. Dransfield
  • D. M. G. Halpin
  • C. E. Jones
  • S. Kilbride
  • Lange, Peter
  • D. A. Lipson
  • D. A. Lomas
  • F. J. Martinez
  • I. Naya
  • S. J. Pascoe
  • R. A. Wise
  • D. Singh
Original languageEnglish
Article numberA102
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume199
Issue numberA2438
ISSN1073-449X
DOIs
Publication statusPublished - 2019

ID: 218435956